• $46.9M
    Market Cap
  • 29.47%
    1-Year Change
  • Biotechnology
    Industry

Top Holders

Institutional
Mutual Funds
Holder
Ownership %
Shares Held
Change (Shares, %)
Report Date
ARMISTICE CAPITAL, LLC
9.52%
4.1M
+4.1M (+100.00%)
Mar 31, 2026
N/A
0.89%
382,469
+382,469 (+100.00%)
Mar 31, 2026
WELLS FARGO & COMPANY/MN
0.61%
264,388
+264,388 (+100.00%)
Mar 31, 2026
GEODE CAPITAL MANAGEMENT, LLC
0.37%
157,485
+47,677 (+30.27%)
Mar 31, 2026
VANGUARD FIDUCIARY TRUST CO
0.15%
64,921
+64,921 (+100.00%)
Mar 31, 2026
RENAISSANCE TECHNOLOGIES LLC
0.15%
62,795
-59,673 (-95.03%)
Mar 31, 2026
STATE STREET CORP
0.10%
43,252
0 (0.00%)
Mar 31, 2026

Current Ownership Distribution

  • Insiders26.3M (61.10%)
  • Other9.2M (21.45%)
  • Institutions5.2M (12.03%)
  • Mutual Funds2.3M (5.42%)

Insider Transactions

  • 61.10% (26.3M)
    Current InsiderOwnership (%, shares)
  • 1
    Number of InsiderBuying (last 12 months)
  • $645,048.56
    Amount of InsiderBuying (last 12 months)
  • 0
    Number of InsiderSelling (last 12 months)
  • $0.00
    Amount of InsiderSelling (last 12 months)
Insider Name & Title
Type
Date
Transaction Value
Shares
Share Price
Shares After Transactions
Xu Jiandong
Chief Financial Officer
Buy
Oct 07, 2025
$1,330.00
1,000
$1.33
265,488
Xu Jiandong
Chief Financial Officer
Buy
Sep 22, 2025
$1,160.00
1,000
$1.16
16,700
Xu Jiandong
Chief Financial Officer
Buy
Sep 11, 2025
$104.00
100
$1.04
264,588
Xu Jiandong
Chief Financial Officer
Award
Oct 30, 2024
$0.00
490,796
$0.00
490,796
Liu Cheng
Chief Executive Officer
Award
Oct 30, 2024
$0.00
490,796
$0.00
490,796
Xu Jiandong
Chief Financial Officer
Award
Oct 30, 2024
$0.00
509,204
$0.00
509,203
Liu Cheng
Chief Executive Officer
Award
Oct 30, 2024
$0.00
509,204
$0.00
509,203